A Salmonella Typhi Controlled Human Infection Study for Assessing Correlation between Bactericidal Antibodies and Protection against Infection Induced by Typhoid Vaccination
Open Access
- 28 June 2021
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 9 (7), 1394
- https://doi.org/10.3390/microorganisms9071394
Abstract
Vi-polysaccharide conjugate vaccines are efficacious against typhoid fever in children living in endemic settings, their recent deployment is a promising step in the control of typhoid fever. However, there is currently no accepted correlate of protection. IgG and IgA antibodies generated in response to Vi conjugate or Vi plain polysaccharide vaccination are important but there are no definitive protective titre thresholds. We adapted a luminescence-based serum bactericidal activity (SBA) for use with S. Typhi and assessed whether bactericidal antibodies induced by either Vi tetanus toxoid conjugate (Vi-TT) or Vi plain polysaccharide (Vi-PS) were associated with protection in a controlled human infection model of typhoid fever. Both Vi-PS and Vi-TT induced significant increase in SBA titre after 28 days (Vi-PS; p < 0.0001, Vi-TT; p = 0.003), however higher SBA titre at the point of challenge did not correlate with protection from infection or reduced symptom severity. We cannot eliminate the role of SBA as part of a multifactorial immune response which protects against infection, however, our results do not support a strong role for SBA as a mechanism of Vi vaccine mediated protection in the CHIM setting.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1084259)
This publication has 33 references indexed in Scilit:
- Serum Bactericidal Assays To Evaluate Typhoidal and Nontyphoidal Salmonella VaccinesClinical and Vaccine Immunology, 2014
- An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate SolutionClinical Infectious Diseases, 2014
- Immunological evaluation of Vi capsular polysaccharide of Salmonella enterica subsp. Typhi vaccine by serum bactericidal assayJournal of Medical Microbiology, 2013
- Vaccines for typhoid fever and other salmonellosesCurrent Opinion in Infectious Diseases, 2012
- Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010Journal of Global Health, 2012
- Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesisMicrobiological Research, 2012
- Antibodies in Action: Role of Human Opsonins in Killing Salmonella enterica Serovar TyphiInfection and Immunity, 2011
- Kinetics of the Natural, Humoral Immune Response toSalmonella entericaSerovar Typhi in Kathmandu, NepalClinical and Vaccine Immunology, 2009
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regionsClinical and Experimental Immunology, 1991